Expanding Access, Ensuring Value: The Next Chapter of GLP-1 Care

As GLP-1 therapies become more accessible through shifting price points, new consumer channels, and evolving benefit designs, the market for them is poised for a new stage of growth. Broader availability is creating opportunities for innovation while also increasing the need for differentiated models that support adherence, engagement, and long-term health. As GLP-1 research advances in areas such as brain health, addiction, and liver disease, these therapies are poised to affect a wider set of clinical and economic decisions across the health system. This session will examine how changing economics, consumer demand, and precision targeting are reshaping the GLP-1 landscape and what these trends mean for scalable and sustainable value across health care.